Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD1b is a membrane-bound glycoprotein that belongs to the group 1 of the CD1 family, which are MHC class I-like molecules. It is encoded by the *CD1B* gene in humans and plays a critical role in presenting lipid and glycolipid antigens to T-cell receptors, particularly on natural killer T-cells and other αβ T-cells. Unlike classical MHC molecules that present peptide antigens, CD1b specializes in presenting self and non-self lipid-based antigens. By presenting diverse lipid antigens—including those derived from pathogens—CD1b-restricted T cells contribute significantly to host defense mechanisms against infections such as tuberculosis. Diseases associated with alterations or dysfunctions involving *CD1B* include follicular dendritic cell sarcoma and non-Langerhans-cell histiocytosis. Additionally, regulatory axes involving miRNAs (e.g., miR‑582/CD1B) have been implicated in dendritic cell function and cancer outcomes.
Not applicable; CD1b is a presenting molecule, not a drug target directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD1b molecule.